Get the app
US › Healthcare

enVVeno Medical Corp (NVNO)

US · Healthcare · Medical Devices

$6.73-3.44%
Last close · 2026-11-06

Latest quarter · ended 2026-09-30

Net profit
$-4.4M
EPS
$-6.29
EPS estimate
$-3.27

EPS came in at -6.29 against a street estimate of -3.27 — a miss of 92.4%.

Key statistics

Market cap
$4.7M
Forward P/E
0.0
P/B
0.24
Book value
$24.32
EPS (TTM)
$-24.99
52-week high
$25.97
52-week low
$6.52
50-day MA
$8.96
200-day MA
$10.29
Beta
1.29

Analyst view

Analysts rate enVVeno Medical Corp a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $30.00.

Shareholding

Insiders
8.08%
Institutions
15.68%

Largest institutional holders

FundStake
Kingdon Capital Management LLC5.21%
CM Management, LLC5.14%
Vanguard Capital Management, LLC0.90%
JPMorgan Chase & Co0.75%
Vanguard Fiduciary Trust Co0.31%
Westside Investment Management, Inc.0.22%
Mirae Asset Global Investments (Korea) Co Ltd0.08%
BlackRock Inc0.06%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for enVVeno Medical Corp — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-11-07.